Click to copy
Press release content from BusinessWire. The AP news staff was not involved in its creation.
Click to copy
PRESS RELEASE: Paid content from BusinessWire
Press release content from BusinessWire. The AP news staff was not involved in its creation.

Biochips - Global Markets to 2023 with Thermo Fisher Scientific, Roche, Illumina, Danaher and Qiagen Dominating - ResearchAndMarkets.com

November 6, 2018

DUBLIN--(BUSINESS WIRE)--Nov 6, 2018--The “Biochip: Global Markets to 2023” report has been added to ResearchAndMarkets.com’s offering.

The biochips market growth outlook is positive with significant growth potential for DNA microarray.

There is pressure on biochip manufacturers to reduce prices of biochips from medical diagnostic companies and research organizations as biochip prices are limiting the growth of the market.

At the same time, increasing the use of biochips in pharmaceutical research and development activities, concerns regarding animal testing, rising use of DNA microarrays for cancer diagnosis is contributing to the growth of the biochips market.

The market for biochips is relatively concentrated. Major players in the market are Thermo Fisher Scientific, Inc., Roche Holding AG, Illumina, Inc., Danaher Corp., and QIAGEN N.V.

The DNA microarray segment accounted for the largest share of the biochips market in 2018. The highest growth is projected to come from the DNA microarray segment. Major factors for this growth included increasing use of DNA microarray in cancer diagnosis and forensic sciences.

North America was the largest region in the biochips market. It was followed by Western Europe and Asia-Pacific. Going forward, Asia-Pacific is expected to witness the fastest growth in the biochips market, followed by North America.

The market is challenged by restraints such as unclear regulatory guidelines, skill shortage and ethical and privacy concerns relating to biochips.

This research report categorizes the biochips market by type. Product types include DNA microarray, protein microarray, tissue/cell and glycan microarrays and lab-on-a-chip.

Companies Profiled

Key Topics Covered

Chapter 2 Summary and Highlights

Chapter 3 Biochips Market Overview

Chapter 4 Biochips Market Patents

Chapter 5 Global Biochips Market Comparison with Macro Economic Factors

Chapter 6 Biochips Market Regional Analysis

Chapter 7 Asia-Pacific Biochips Market

Chapter 8 Western Europe Biochips Market

Chapter 9 Eastern Europe Biochips Market

Chapter 10 North America Biochips Market

Chapter 11 South America Biochips Market

Chapter 12 Middle East Biochips Market

Chapter 13 Africa Biochips Market

Chapter 14 Biochips Market Competitive Landscape

Chapter 15 Key Mergers and Acquisitions in the Biochips Market

For more information about this report visit https://www.researchandmarkets.com/research/6zcs59/biochips_global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181106005388/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Biotechnology



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/06/2018 05:20 AM/DISC: 11/06/2018 05:20 AM


All contents © copyright 2019 The Associated Press. All rights reserved.